Bio Protocol vs Inspect — how do they compare? Bio Protocol trades at Rp511.73 (market cap Rp1,15T, Rp263,61M 24h volume), while Inspect trades at Rp10.84 (market cap Rp7,66M, Rp3,14M 24h volume). The key difference: Bio Protocol is far larger — about 150130.5× Inspect's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 798,4M / 1B INSP (80%) for Inspect. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Inspect for 16 Days on average.
| BIO | INSP | |
|---|---|---|
Market Cap | Rp1,15T | Rp7,66M |
Volume (24h) | Rp263,61M | Rp3,14M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 798,4M / 1B INSP (80%) |
Typical Hold Time | 16 Days | 16 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
INSP token shows limited market activity with a modest market cap of Rp7.66 million and 80% circulating supply. The token demonstrates low trading volume and network activity, with an average hold time of 16 days suggesting minimal speculative interest. Recent on-chain metrics indicate stagnant adoption and limited ecosystem development. Technical analysis reveals narrow trading ranges with no significant price momentum or breakout patterns emerging from current levels.
Overall outlook remains cautious due to low liquidity and limited utility development. Key opportunities include potential ecosystem expansion, while major risks involve liquidity constraints and regulatory uncertainty in the Indonesian crypto market. Investors should monitor for increased network activity and exchange listings that could improve market depth.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Inspect is a Layer 2 protocol suite for Bittensor, designed to facilitate scalable financial activities on TAO. It supports a coordinated ecosystem of products, including TaoFlow (yield and leverage), Substrike (mining pools), NeuralGate (cross-chain access), and taoUSD (stablecoin liquidity). These products benefit users, agents, and protocols involved in decentralized AI. Inspect connects AI, capital, and community to spur genuine economic activity around TAO.
Read more on INSP →